HOSNY AHMED ABDELGAWAD ABDELKAREEM

Mr. HOSNY AHMED ABDELGAWAD ABDELKAREEM

Aswan University, Aswān, Egypt
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2022
Verified
Journal Article
Open access
PDF file
DADOSSEH AFAYIBO
DOSSEH AFAYIBO
HZHong Zhu
Hong Zhu
BZBeibei Zhang
Beibei Zhang
LYLan Yao
Lan Yao
HAHOSNY AHMED ABDELGAWAD ABDELKAREEM
HOSNY AHMED ABDELGAWAD ABDELKAREEM
Shaohui WangShaohui Wang
Shaohui Wang
Avian pathogenic Escherichia coli (APEC) causes colibacillosis in avians, resulting in considerable losses in the poultry industry. APEC showed zoonotic potential initially related to the fact that APEC serves as the reservoir of virulence genes and antibiotic resistance genes for other E. coli. Thus, we determine the serotypes, phylogenetic groups, virulence genes distribution, and antibiotic resistance profiles of APEC isolates in eastern China. A total of 230 APEC were isolated from diseased chicken and duck with typical colibacillosis symptoms. Serotyping identified that O78 (44.78%) was the predominant serotype. The majority of APEC isolates were classified into B2 (29.57%), A (26.96%), D (20.00%), and B1 (18.26%), respectively. Among the 15 virulence genes, a high prevalence of ibeB (99.57%), fimC (91.74%), mat (91.30%), ompA (83.04%), and iss (80.43%) genes was observed. Except for low resistance rates for imipenem (1.7%) and polymyxin B (0.4%), most of the APEC isolates were resistant to erythromycin (98.7%), enrofloxacin (96.1%), tetracycline (95.2%), doxycycline (93.9%), lincomycin (90.0%), and streptomycin (90.0%). Moreover, all APEC exhibit multi-drug resistance. This study indicated that APEC isolates harbor a variety of virulence genes and showed multi-antibiotic resistance profiles, providing proof for understanding the epidemiological background and zoonotic potential of APEC in poultry farms.

20 November 2024 in Fish & Shellfish Immunology
Verified
Journal Article
Closed access
HMHeba H. Mahboub
Heba H. Mahboub
Morteza YousefiMorteza Yousefi
Morteza Yousefi
HAHOSNY AHMED ABDELGAWAD ABDELKAREEM
HOSNY AHMED ABDELGAWAD ABDELKAREEM
AAAbdel-Wahab A Abdelwarith
Abdel-Wahab A Abdelwarith
EYElsayed M. Younis
Elsayed M. Younis
ARAfaf Abdel Rahman
Afaf Abdel Rahman

13 November 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AHAhmed HASSANEEN
Ahmed HASSANEEN
AZAnis Anis Mohamed Zaid
Anis Anis Mohamed Zaid
SNSafaa Y Nour
Safaa Y Nour
RMRasha Salah Mohamed
Rasha Salah Mohamed
Islam Mohamed WassifIslam Mohamed Wassif
Islam Mohamed Wassif
RMRagab H Mohamed
Ragab H Mohamed
Brucellosis in dromedary camel bulls leads to either temporary or permanent loss of fertility. Camel brucellosis is associated with both orchitis and epididymitis. However, the clinical signs of camel brucellosis are not clear as those in cattle. Therefore, this study aimed to diagnose camel brucellosis based on a serological screening using Rose Bengal plate test (RBPT) followed by competitive ELISA. To understand the impact of brucellosis on camel bull fertility, this study aimed to examine the semen characteristics, evaluate the testicular histopathology, examine hormonal profile, antioxidants and acute phase proteins (APP). A total of 150 mature bulls were used in this study. Blood samples were collected for serological, hormonal, and biochemical analysis. This study revealed that 6.6% and 7.3% of the examined bulls were Brucella-seropositive using RBPT and competitive ELISA, respectively. The Brucella-seropositive dromedary bulls showed poor semen quality, pathological changes orchitis, and lower testosterone. Moreover, our findings showed a higher cortisol level, and significant impairments in the measured APP and antioxidants in Brucella-seropositive bulls. In conclusion, the Brucella-seropositive dromedary bulls showed lower fertility due to poor semen quality and lower testosterone levels. Such lower fertility is likely mediated by high cortisol levels, and impaired APP and antioxidants’ defense response.

21 July 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
HAHOSNY AHMED ABDELGAWAD ABDELKAREEM
HOSNY AHMED ABDELGAWAD ABDELKAREEM
ZLZhengmin Lian
Zhengmin Lian
YYYi Yin
Yi Yin
TFTian Fang
Tian Fang
Mingxing TianMingxing Tian
Mingxing Tian
SYShengqing Yu
Shengqing Yu
Background: Brucella abortus is the main causative agent for bovine brucellosis. B. abortus A19 is a widely used vaccine strain to protect cows from Brucella infection in China. However, A19 has a similar lipopolysaccharide (LPS) antigen to that of the field virulent Brucella strain, whose immunization interferes with the serodiagnosis of vaccinated and infected animals. [Aim] To develop a novel Brucella DIVA vaccine candidate. Study design and methods: The B. abortus mutant A19mut2 with the formyltransferase gene wbkC is replaced by an acetyltransferase gene wbdR from E. coli O157 using the bacterial homologous recombination technique, generating a modified O-polysaccharide that cannot induce antibodies in mice against wild-type Brucella LPS. The biological phenotypes of the A19mut2 were assessed using a growth curve analysis, agglutination tests, Western blotting, and stress resistance assays. Histopathological changes and bacterial colonization in the spleens of vaccinated mice were investigated to assess the residual virulence and protection of the A19mut2. Humoral and cellular immunity was evaluated by measuring the levels of IgG, IgG subtypes, and the release of cytokines IFN-γ and IL10 in the splenocytes of the vaccinated mice. ELISA coated with wild-type LPS can distinguish mouse antibodies induced by A19 and A19mut2 immunization. Results: The A19mut2 showed a decreased residual virulence in mice, compared to the A19 strain, but induced significant humoral and cellular immune responses, as the A19 immunization did. The protection efficacy of A19mut2 immunization against B. abortus S2308 NalR infection was similar to that of A19 immunization. Conclusion: The A19mut2 has potential as a novel DIVA vaccine candidate in the future.